Why BioNTech Stock Is Bouncing Back Today
Published
Investors appear to think last week's sell-off was overdone.
Full ArticlePublished
Investors appear to think last week's sell-off was overdone.
Full ArticleGood news for Pfizer was seen as potentially bad news for BioNTech.
Moderna's disappointing Q3 report appears to be dragging BioNTech's shares down with it..